Guaifenesin and dropropizine were analyzed through oxidation with periodic acid to give formaldehyde which was allowed to condense with 4-Amino-5-hydrazino-4H [1,2,4]-triazole-3-thiol (AHTT). The condensation product was further oxidized to yield a purple colored compound with maximum absorption at 550?nm. Beer's law was obeyed in the range of 5–45? g for guaifenesin and 10–80? g for dropropizine. Both drugs were also successfully determined in their dosage forms. 1. Introduction Guaifenesin (GF), 3-(2-Methoxyphenoxy)-1,2-propanediol; is reported to increase the volume and reduce the viscosity of tenacious sputum and is used as expectorant for productive cough [1]. Different methods have been reported for the analysis of GF including HPLC [2–8], GC [9, 10], capillary electrophoresis mass spectrometry [11], X-ray diffraction [12], voltammetry [13]. Dropropizine (DP), 3-(4-Phenyl-1-piperazinyl)-1,2-propanediol, is a cough suppressant reported to have a peripheral action in nonproductive cough [1]. Only two GC-mass spectrometry methods have been reported for the determination of DP in biological fluids [14, 15] in addition to a manufacturer procedure that involves the determination of dropropizine by measuring its UV absorbance at 237?nm in 0.05?N HCl (personal contact): Bromhexine HCl (BR), 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine hydrochloride; N-(2-Amino-3,5-dibromobenzyl)-N-methylcyclohexylamine hydrochloride: The aim of the present paper is to develop a simple and accurate method for the determination of dropropizine and guaifenesin that permits their analysis in dosage forms without interference from excipients and other coformulated drugs. 2. Experimental 2.1. Chemicals and Reagents Purpald or 4-Amino-5-hydrazino-4H [ ]-triazole-3-thiol reagent (AHTT) (Sigma-Aldrich) was prepared as 0.5% in 0.5?M hydrochloric acid. Periodic acid (Winlab, UK.) was prepared as 1? solution in 0.2?M potassium hydroxide. HPLC grade acetonitrile was from Fisher Scientific, UK. Potassium dihydrogen phosphate was from Sigma-Aldrich Chemie, Germany. All other chemicals used were of analytical grade and water was freshly distilled. 2.2. Materials Reference standard guaifenesin (GF), dropropizine (DP) and bromhexine HCl (BR) were kindly supplied by Rameda Co. for pharmaceutical industries and diagnostic reagents, EVA Pharma for pharmaceutical and medical appliances and EVA Pharma for pharmaceutical and medical appliances, respectively. 2.3. Pharmaceutical Preparations Muclear Capsules: It is a product of Rameda Co., Batch No. 08455, claimed to contain 100?mg
References
[1]
P. Khathleen, Martindale: The Complete Drug Reference, (PhP) Pharmaceutical Press, London, UK, 32nd edition, 1999.
[2]
S. M. Amer, S. S. Abbas, M. A. Shehata, and N. M. Ali, “Simultaneous determination of phenylephrine hydrochloride, guaifenesin, and chlorpheniramine maleate in cough syrup by gradient liquid chromatography,” Journal of AOAC International, vol. 91, no. 2, pp. 276–284, 2008.
[3]
M. Vasudevan, S. Ravisankar, M. George, and J. Ravi, “Simultaneous estimation of terbutaline, bromhexine and guaiphenesin in soft gelatin capsules by HPLC method,” Indian Drugs, vol. 37, no. 10, pp. 489–492, 2000.
[4]
V. Galli and C. Barbas, “High-performance liquid chromatographic analysis of dextromethorphan, guaifenesin and benzoate in a cough syrup for stability testing,” Journal of Chromatography A, vol. 1048, no. 2, pp. 207–211, 2004.
[5]
M. L. Wilcox and J. T. Stewart, “HPLC determination of guaifenesin with selected medications on underivatized silica with an aqueous-organic mobile phase,” Journal of Pharmaceutical and Biomedical Analysis, vol. 23, no. 5, pp. 909–916, 2000.
[6]
L. A. Shervington, “A quantitative simultaneous high performance liquid chromatographic determination of pseudoephedrine HCl, guaifenesin and dextromethorphan HBr,” Analytical Letters, vol. 30, no. 5, pp. 927–944, 1997.
[7]
T. D. Wilson, W. G. Jump, W. C. Neumann, and T. San Martin, “Validation of improved methods for high-performance liquid chromatographic determination of phenylpropanolamine, dextromethorphan, guaifenesin and sodium benzoate in a cough-cold formulation,” Journal of Chromatography, vol. 641, no. 2, pp. 241–248, 1993.
[8]
S. Stavchansky, S. Demirbas, L. Reyderman, and C.-K. Chai, “Simultaneous determination of dextrorphan and guaifenesin in human plasma by liquid chromatography with fluorescence detection,” Journal of Pharmaceutical and Biomedical Analysis, vol. 13, no. 7, pp. 919–925, 1995.
[9]
T. Harsono, M. Yuwono, and G. Indrayanto, “Simultaneous determination of some active ingredients in cough and cold preparations by gas chromatography, and method validation,” Journal of AOAC International, vol. 88, no. 4, pp. 1093–1098, 2005.
[10]
M. H. M. Sharaf and D. D. Stiff, “Determination of guaifenesin in human serum by capillary gas chromatography and electron capture detection,” Journal of Pharmaceutical and Biomedical Analysis, vol. 35, no. 4, pp. 801–806, 2004.
[11]
Y. Tanaka, Y. Kishimoto, K. Otsuka, and S. Terabe, “Strategy for selecting separation solutions in capillary electrophoresis-mass spectrometry,” Journal of Chromatography A, vol. 817, no. 1-2, pp. 49–57, 1998.
[12]
T. Grygar, O. Frybort, P. Bezdi?ka, and T. Pekárek, “Quantitative analysis of antipyretics and analgesics in solid dosage forms by powder X-ray diffraction,” Chemia Analityczna, vol. 53, no. 2, pp. 187–200, 2008.
[13]
I. Tapsoba, J.-E. Belgaied, and K. Boujlel, “Voltammetric assay of Guaifenesin in pharmaceutical formulation,” Journal of Pharmaceutical and Biomedical Analysis, vol. 38, no. 1, pp. 162–165, 2005.
[14]
R. F. Staack, D. S. Theobald, and H. H. Maurer, “Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry,” Therapeutic Drug Monitoring, vol. 26, no. 4, pp. 441–449, 2004.
[15]
P. Zaratin, L. De Angelis, and F. Cattabeni, “Gas chromatographic-mass spectrometric determination of levodropropizine plasma levels in healthy volunteers,” Arzneimittel-Forschung, vol. 38, no. 8, pp. 1156–1158, 1988.
[16]
N. W. Jacobsen and R. G. Dickinson, “Spectrometric assay of aldehydes as 6-mercapto-3-substituted-s-triazolo(4,3-b)-s-tetrazines,” Analytical Chemistry, vol. 46, no. 2, pp. 298–299, 1974.
[17]
H. Mimura, M. Kanebo, N. Nishigams, S. Fukui, and S. Kanno, “The determination of formaldehyde by the 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole method,” Eisei Kagaku, vol. 22, p. 39, 1967, Through Chemistry Abstract, vol. 85, article 71809, 1976.
[18]
O. M. Abdullah and S. E.-S. Barakat, “Spectrophotometric determination of glucosamine and mannitol with 4-amino-5-hydrazino-4H[1,2,4]-triazole-3-thiol in pharmaceutical formulations,” Saudi Pharmaceutical Journal, vol. 13, no. 4, pp. 185–191, 2005.
[19]
The European Agency for the Evaluation of Medical Products, “ICH Topic Q2B Note for Guidance on Validation of Analytical Procedures,” Methodology GPMP/ICH/1995, pp. 281- 295.